617 related articles for article (PubMed ID: 21362322)
1. Glycemic variability in insulin treated type 2 diabetes with well-controlled hemoglobin A1c and its response to further treatment with acarbose.
Su JB; Wang XQ; Chen JF; Wu G; Jin Y
Chin Med J (Engl); 2011 Jan; 124(1):144-7. PubMed ID: 21362322
[TBL] [Abstract][Full Text] [Related]
2. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
[TBL] [Abstract][Full Text] [Related]
3. Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.
Derosa G; Franzetti I; Querci F; D'Angelo A; Maffioli P
Pharmacotherapy; 2015 Nov; 35(11):983-90. PubMed ID: 26598090
[TBL] [Abstract][Full Text] [Related]
4. Glipizide controlled-release tablets, with or without acarbose, improve glycaemic variability in newly diagnosed Type 2 diabetes.
Bao YQ; Zhou J; Zhou M; Cheng YJ; Lu W; Pan XP; Tang JL; Lu HJ; Jia WP
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):564-8. PubMed ID: 20082624
[TBL] [Abstract][Full Text] [Related]
5. Nateglinide and acarbose are comparably effective reducers of postprandial glycemic excursions in chinese antihyperglycemic agent-naive subjects with type 2 diabetes.
Zhou J; Li H; Zhang X; Peng Y; Mo Y; Bao Y; Jia W
Diabetes Technol Ther; 2013 Jun; 15(6):481-8. PubMed ID: 23631607
[TBL] [Abstract][Full Text] [Related]
6. Glycemic excursions are positively associated with changes in duration of asymptomatic hypoglycemia after treatment intensification in patients with type 2 diabetes.
Wang JS; Lee IT; Lee WJ; Lin SD; Su SL; Tu ST; Tseng YH; Lin SY; Sheu WH
Diabetes Res Clin Pract; 2016 Mar; 113():108-15. PubMed ID: 26810269
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Acarbose on Glycemic Variability in Patients with Type 2 Diabetes Mellitus Using Premixed Insulin Compared to Metformin (AIM): An Open-Label Randomized Trial.
Gao F; Ma X; Peng J; Lu J; Lu W; Zhu W; Bao Y; Vigersky RA; Jia W; Zhou J
Diabetes Technol Ther; 2020 Apr; 22(4):256-264. PubMed ID: 31638433
[No Abstract] [Full Text] [Related]
8. Glycemic excursions are positively associated with HbA1c reduction from baseline after treatment with acarbose in patients with type 2 diabetes on metformin monotherapy.
Wang JS; Lee IT; Lee WJ; Lin SD; Su SL; Tu ST; Tseng YH; Lin SY; Sheu WH
J Diabetes; 2017 Mar; 9(3):248-255. PubMed ID: 27043224
[TBL] [Abstract][Full Text] [Related]
9. Effects of acarbose and siglitine on blood glucose fluctuation and islet β-cell function in patients with type 2 diabetes mellitus.
Wang RR; Lv ZM; Dan YP; Chen KY; Zhang C
J Biol Regul Homeost Agents; 2019; 33(2):365-374. PubMed ID: 30972995
[TBL] [Abstract][Full Text] [Related]
10. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
11. Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.
Swami V; Yadav SK; Saxena P; Sharma A; Dash CK; Gupta A
J Assoc Physicians India; 2024 Jan; 72(1):18-21. PubMed ID: 38736069
[TBL] [Abstract][Full Text] [Related]
12. The investigation of the efficacy of insulin glargine on glycemic control when combined with either repaglinide or acarbose in obese Type 2 diabetic patients.
Duran C; Tuncel E; Ersoy C; Ercan I; Selimoglu H; Kiyici S; Guclu M; Erturk E; Imamoglu S
J Endocrinol Invest; 2009 Jan; 32(1):69-73. PubMed ID: 19337019
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with glycemic variability in children with type 1 diabetes mellitus based on flash glucose monitoring system.
Zhang L; Guo K; Xu Y; Bai J; Ma Y; Fu L; Liu J; Hu K; Li X; Jiang H; Yang L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):462-468. PubMed ID: 35545341
[TBL] [Abstract][Full Text] [Related]
14. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
[TBL] [Abstract][Full Text] [Related]
15. [Post-hoc analyses of type 2 diabetes patients switch from premixed insulin regimen to basal insulin plus oral hypoglycemic agents regimen].
Bu S; Guo XH; Yang WY; Lu GZ; Yang ZJ; Ren TT; Gao Y
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3115-8. PubMed ID: 18269868
[TBL] [Abstract][Full Text] [Related]
16. The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM).
Sartore G; Chilelli NC; Burlina S; Di Stefano P; Piarulli F; Fedele D; Mosca A; Lapolla A
Acta Diabetol; 2012 Dec; 49 Suppl 1():S153-60. PubMed ID: 22466072
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized, open-label study comparing the efficacy and safety of preprandial and prandial insulin in combination with acarbose in elderly, insulin-requiring patients with type 2 diabetes mellitus.
Yang G; Li C; Gong Y; Li J; Cheng X; Tian H
Diabetes Technol Ther; 2013 Jun; 15(6):513-9. PubMed ID: 23530576
[TBL] [Abstract][Full Text] [Related]
18. Effects of mulberry twig alkaloids(Sangzhi alkaloids) and metformin on blood glucose fluctuations in combination with premixed insulin-treated patients with type 2 diabetes.
Meng Z; Xu C; Liu H; Gao X; Li X; Lin W; Ma X; Yang C; Hao M; Zhao K; Hu Y; Wang Y; Kuang H
Front Endocrinol (Lausanne); 2023; 14():1272112. PubMed ID: 38027146
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycemia observed during continuous glucose monitoring in patients with type 2 diabetes mellitus treated by subcutaneous insulin injection.
Ito H; Abe M; Shinozaki M; Oshikiri K; Yamashita H; Nakashima M; Takaki A; Yukawa C; Furusho M; Antoku S; Mifune M; Togane M
Diabetes Technol Ther; 2013 Jul; 15(7):586-90. PubMed ID: 23578166
[TBL] [Abstract][Full Text] [Related]
20. The beneficial effect of α-glucosidase inhibitor on glucose variability compared with sulfonylurea in Taiwanese type 2 diabetic patients inadequately controlled with metformin: preliminary data.
Lin SD; Wang JS; Hsu SR; Sheu WH; Tu ST; Lee IT; Su SL; Lin SY; Wang SY; Hsieh MC
J Diabetes Complications; 2011; 25(5):332-8. PubMed ID: 21813293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
